To describe a case of a possible incipient Stevens–Johnson reaction while a patient had been on a stable dose of lamotrigine for several months and to consider the likely cause.
Methods:
The history is recounted.
Results:
One likely cause implicates differing effective doses of lamotrigine across differing brands and raises quality control issues.
Conclusion:
The patient’s severe reaction may reflect changing to a brand of lamotrigine that precipitously generated a higher serum level of lamotrigine.
CalabreseJRSullivanJRBowdenCL. Rash in multicentre trials of lamotrigine in mood disorders: clinical relevance and management. J Clin Psychiat2002; 63: 1012–1019.
2.
MoreiraBThomé-SouzaSValenteK. Late side-effects of valproate and lamotrigine. J Epilepsy Clin Neurophysiol2007; 13: 187–189.